- Home
- ivory coast
- Companies
Refine by
Industries served
- Medical / Health Care
- Agriculture
- Energy
- Monitoring and Testing
- Water and Wastewater
- Chemical & Pharmaceuticals
- Environmental
- Manufacturing, Other
- Electronics and Computers
- Oil, Gas & Refineries
- Health and Safety
- Aerospace & Air Transport
- Metal
- Air and Climate
- Plastics & Resins
- Waste and Recycling
- University / Academia / Research
- Food and Beverage
- Mining
- Automobile & Ground Transport
- Banking & Finance / Insurance / Legal
- Defense
- Paint
- Communications / Telecom / Datacom
- Construction & Construction Materials
- Furniture
- Dry Cleaning
- Domestic
- Forestry & Wood
- Glassware
- Packaging
- Commercial
- Logistics
- Leather & Tanning
- Printing
- Textile
- Soil and Groundwater
- Government
Medical Industry Technology Near Ivory Coast
489 companies found
Technologybased inBoston, MASSACHUSETTS (USA)
Statsols is the company behind nQuery. nQuery is the complete trial design platform to make clinical trials faster, less costly and more successful. For over 20 years, we have worked with biostatisticians and researchers all over the world to ensure ...
Sample size for Bayesian trial design. Use Bayesian Assurance for better decisions at key clinical trial ...
Technologybased inPhoenix, ARIZONA (USA)
Datavant makes the world’s health data secure, accessible and usable. Datavant is a data platform company for healthcare whose products and solutions enable organizations to move and connect data securely. Through proprietary technology, the ...
One of the most common requests from patients is “how to get medical records.” The Switchboard patient request experience saves time and resources by providing a user-friendly way to request medical records anytime, from anywhere. ...
Technologybased inDurham, NORTH CAROLINA (USA)
Tryton Medical is a leading developer of novel stent systems for the treatment of bifurcation lesions. The co-founders of the company, Aaron V. Kaplan M.D. and H. Richard Davis, recognized an unmet need in coronary artery disease treatment. ...
The Tryton Side Branch Stent is deployed in the side branch artery using a standard single-wire, balloon-expandable stent delivery system. The open architecture of the Tryton stent allows for integration of a conventional drug eluting stent for the ...
Technologybased inMemphis, TENNESSEE (USA)
The Spesana Healthcare platform is an intelligent overlay of existing systems that allows for all stakeholders in a patient's care the ability to connect without barriers thereby optimizing care. We are the team that developed the first oncology ...
Our technology dynamically integrates the patient, the provider and the payer and optimizes healthcare data into critical workflows with artificial intelligence and automation. Our capabilities are comprehensive, expanding into the overall ...
Technologybased inMenlo Park, CALIFORNIA (USA)
We’re a precision diagnostics company that quantifies biology to create powerful molecular diagnostics. We work to improve disease detection by counting molecules with our proprietary molecular counting platform. We place patients at the forefront ...
Shifting the Paradigm of Prenatal Screening: The name of our non-invasive prenatal test (NIPT) is appropriately called “UNITY” as it brings together fetal screening for aneuploidies and recessive conditions. It also represents uniting ...
Technologybased inSuwon, SOUTH KOREA
Onegene Biotechnology develops transformative therapeutics for the chronic and complex diseases. Our UniStac platform allows rationale-based design of multispecific drug in true plug-and-play ...
OGB21502 is an augmented FGF21 on a nonclinical stage that is conjugated to albumin, GLP-1, GCG, and α-cytokine. This tetra-specific, tetra-valent molecule is only 120 kDa in size, demonstrating good physical stability. This well-balanced ...
Technologybased inKirkland, WASHINGTON (USA)
Heart failure is a progressive disease. It’s an expensive disease. It’s a devastating disease. Over 20% of heart failure patients with FMR die within the first year of diagnosis and 50% die within five years.1 Each year thousands of these patients ...
A completely different and much earlier approach to treating functional mitral regurgitation (FMR) than any other device therapy currently available to patients. The goal: Treat the condition—not just the symptoms. The Carillon System is ...
Technologybased inSyracuse, NEW YORK (USA)
AptaMatrix is a privately held, biotechnology company headquartered in Syracuse, New York. The company’s focus is to accelerate aptamer discovery using its patented Acyclic Identification of Aptamers™ (AIA™) & multiplexed AIA (mAIA™) approaches, ...
Aptamers are DNA/RNA molecules that have affinities for their targets similar to antibodies. Aptamers have shown great potential to replace antibodies in biosensors, point-of-care diagnostics, therapeutics, and all of the areas currently dominated ...
Technologybased inParis, FRANCE
Curadigm is an early-stage company focused on shifting the paradigm of therapeutic clearance, bioavailability, and efficacy to improve treatment outcomes for millions of patients. Curadigm was spun-off from Nanobiotix, a late-stage clinical company, ...
Technologybased inHamburg, GERMANY
We are specialized in expanded primary cells and media (upcyte) as well as custom cell line development (ixcyte). Cells are our passion! If you are looking for a reliable partner for your project, we’ve got you covered. Our team of experienced ...
Liver sinusoidal endothelial cells (LSECs) are highly specialized cells that form the scavenger endothelium within the liver. They exhibit extraordinarily high uptake of soluble waste molecules (< 0.23 µm), thus playing an important role in ...
Technologybased inCoral Gables, FLORIDA (USA)
We are a late-stage biotech company addressing diseases of the central nervous system (CNS), with a focus on major depressive disorder (MDD). Our experienced and dedicated team is committed to making a difference in the lives of patients and their ...
Novel MOA: REL-1017 works as an NMDAR channel blocker with preferential activity at hyperactive GluN1-GluN2D channels. REL-1017 is a novel N-methyl-D-aspartate receptor (NMDAR) channel blocker in phase 3 clinical trials for the treatment of Major ...
Technologybased inCascina (Pi), ITALY
Endotics: robotic disposable colonoscopy for safer and painless procedures - ''...All patients rated the robotic colonoscopy as virtually ...
The Robotic Disposable Colonoscope With Surgical Capability, Designed To Allow A Painless, Safer And Easier Procedure. The Endotics® System can make pain-free colonoscopies a reality - without resorting to sedation. The Endotics® ...
Technologybased inRehovot, ISRAEL
Biolojic Design is committed to curing patients by designing and developing a pipeline of revolutionary therapeutics. Biolojic’s platform generates antibodies that bind to predefined epitopes, thus allowing for the design of specific functions: ...
Redefining What Antibodies Can Do: Biolojic’s platform generates antibodies that bind to predefined epitopes, thus allowing for the design of specific functions: agonism, antagonism and selective binding. The platform also generates ...
Technologybased inManhattan Beach, CALIFORNIA (USA)
Medtor is a early revenue-stage privately funded entity located in Manhattan Beach, CA and focused on leveraging patented optical technology to bring medical grade vital signs monitoring to wearable platforms. The company has already developed a ...
Medtor’s technology produces two separate and independent data streams that provide enhanced precision and accuracy. One data stream is based on two-wavelength illumination, and the other reveals precise tissue properties from spectral white ...
Technologybased inDublin 8, IRELAND
The founders have developed the present technology for the past 7 years. The team is currently developing predictors for fitness and health, powered by deep learning, for our present and future products. Located in the technological hub of Dublin, ...
Technologybased inSouth San Francisco, CALIFORNIA (USA)
Superfluid’s platform technology is applicable to a wide variety of diseases. We are currently focused on Alzheimer’s Disease, where there are urgent medical needs. This minimally invasive approach eliminates the need for spinal taps and ...
Technologybased inOttawa, SWITZERLAND
Orion Biotechnology is unlocking the therapeutic potential of previously undruggable G Protein-Coupled Receptors (GPCRs) with a novel drug modality, proven discovery platform and best-in-class molecules. The company is advancing a diversified ...
G Protein-Coupled Receptors (GPCRs) are involved in a wide range of physiological and pathological processes and represent a large class of drug targets accounting for >30% of all drugs on the market. These drugs, however, only cover 15% of the ...
Technologybased in, PENNSYLVANIA (USA)
We're a team of engineers, scientists, and physicians building the future of medical technology. Our goal is democratize tools for clinical decision support. We are alumni from Imperial College London, University College London, Oxford University, ...
Respiratory rate (FDA-cleared), Respiratory patterns, Movement , Presence, Ambient Sound & ...
Technologybased inCambridge, MASSACHUSETTS (USA)
Vaxxas is commercializing novel technology that dramatically enhances the performance of existing and next-generation vaccines. The company believes its innovative needle-free technology will be fundamental to help the world in rethinking what's ...
Technologybased inYongin-si, SOUTH KOREA
Vivozon is a global innovative drug development company established in 2008. We built an efficacy-based new drug discovery system that is clearly distinct from the existing new drug development paradigm, and discovered the non- narcotic analgesic ...
Opiranserin (VVZ-149) for injection is a first-in-class non-narcotic analgesic under development by Vivozon. As atreatment for postoperative pain used as a first-line therapy in the global market, Opiranserin aims to ultimately replaceopioid ...
